These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21362533)

  • 1. Left ventricular dysfunction in murine models of heart failure and in failing human heart is associated with a selective decrease in the expression of caveolin-3.
    Feiner EC; Chung P; Jasmin JF; Zhang J; Whitaker-Menezes D; Myers V; Song J; Feldman EW; Funakoshi H; Degeorge BR; Yelamarty RV; Koch WJ; Lisanti MP; McTiernan CF; Cheung JY; Bristow MR; Chan TO; Feldman AM
    J Card Fail; 2011 Mar; 17(3):253-63. PubMed ID: 21362533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled and cardiac-restricted overexpression of the arginine vasopressin V1A receptor causes reversible left ventricular dysfunction through Gαq-mediated cell signaling.
    Li X; Chan TO; Myers V; Chowdhury I; Zhang XQ; Song J; Zhang J; Andrel J; Funakoshi H; Robbins J; Koch WJ; Hyslop T; Cheung JY; Feldman AM
    Circulation; 2011 Aug; 124(5):572-81. PubMed ID: 21747049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A1 adenosine receptor upregulation accompanies decreasing myocardial adenosine levels in mice with left ventricular dysfunction.
    Funakoshi H; Zacharia LC; Tang Z; Zhang J; Lee LL; Good JC; Herrmann DE; Higuchi Y; Koch WJ; Jackson EK; Chan TO; Feldman AM
    Circulation; 2007 May; 115(17):2307-15. PubMed ID: 17438146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1/3 double-knockout mice are viable, but lack both muscle and non-muscle caveolae, and develop a severe cardiomyopathic phenotype.
    Park DS; Woodman SE; Schubert W; Cohen AW; Frank PG; Chandra M; Shirani J; Razani B; Tang B; Jelicks LA; Factor SM; Weiss LM; Tanowitz HB; Lisanti MP
    Am J Pathol; 2002 Jun; 160(6):2207-17. PubMed ID: 12057923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of Acyl Coenzyme A Attenuates Pathological and Metabolic Cardiac Remodeling Through Selective Lipid Trafficking.
    Goldenberg JR; Carley AN; Ji R; Zhang X; Fasano M; Schulze PC; Lewandowski ED
    Circulation; 2019 Jun; 139(24):2765-2777. PubMed ID: 30909726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ecto-5'-nucleotidase deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction.
    Xu X; Fassett J; Hu X; Zhu G; Lu Z; Li Y; Schnermann J; Bache RJ; Chen Y
    Hypertension; 2008 Jun; 51(6):1557-64. PubMed ID: 18391093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha.
    Janczewski AM; Kadokami T; Lemster B; Frye CS; McTiernan CF; Feldman AM
    Am J Physiol Heart Circ Physiol; 2003 Mar; 284(3):H960-9. PubMed ID: 12578819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered calcium transient and development of hypertrophy in beta2-adrenoceptor overexpressing mice with and without pressure overload.
    Schwarz B; Percy E; Gao XM; Dart AM; Richardt G; Du XJ
    Eur J Heart Fail; 2003 Mar; 5(2):131-6. PubMed ID: 12644002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanical unloading increases caveolin expression in the failing human heart.
    Uray IP; Connelly JH; Frazier OH; Taegtmeyer H; Davies PJ
    Cardiovasc Res; 2003 Jul; 59(1):57-66. PubMed ID: 12829176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intercellular Adhesion Molecule 1 Regulates Left Ventricular Leukocyte Infiltration, Cardiac Remodeling, and Function in Pressure Overload-Induced Heart Failure.
    Salvador AM; Nevers T; Velázquez F; Aronovitz M; Wang B; Abadía Molina A; Jaffe IZ; Karas RH; Blanton RM; Alcaide P
    J Am Heart Assoc; 2016 Mar; 5(3):e003126. PubMed ID: 27068635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac-specific overexpression of caveolin-3 attenuates cardiac hypertrophy and increases natriuretic peptide expression and signaling.
    Horikawa YT; Panneerselvam M; Kawaraguchi Y; Tsutsumi YM; Ali SS; Balijepalli RC; Murray F; Head BP; Niesman IR; Rieg T; Vallon V; Insel PA; Patel HH; Roth DM
    J Am Coll Cardiol; 2011 May; 57(22):2273-83. PubMed ID: 21616289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure.
    Yurista SR; Matsuura TR; Silljé HHW; Nijholt KT; McDaid KS; Shewale SV; Leone TC; Newman JC; Verdin E; van Veldhuisen DJ; de Boer RA; Kelly DP; Westenbrink BD
    Circ Heart Fail; 2021 Jan; 14(1):e007684. PubMed ID: 33356362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac resynchronization therapy restores sympathovagal balance in the failing heart by differential remodeling of cholinergic signaling.
    DeMazumder D; Kass DA; O'Rourke B; Tomaselli GF
    Circ Res; 2015 May; 116(10):1691-9. PubMed ID: 25733594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caveolin-1 and -3 dissociations from caveolae to cytosol in the heart during aging and after myocardial infarction in rat.
    Ratajczak P; Damy T; Heymes C; Oliviéro P; Marotte F; Robidel E; Sercombe R; Boczkowski J; Rappaport L; Samuel JL
    Cardiovasc Res; 2003 Feb; 57(2):358-69. PubMed ID: 12566108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukemia inhibitory factor is augmented in the heart in experimental heart failure.
    Jougasaki M; Leskinen H; Larsen AM; Cataliotti A; Chen HH; Burnett JC
    Eur J Heart Fail; 2003 Mar; 5(2):137-45. PubMed ID: 12644003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenic overexpression of caveolin-3 in the heart induces a cardiomyopathic phenotype.
    Aravamudan B; Volonte D; Ramani R; Gursoy E; Lisanti MP; London B; Galbiati F
    Hum Mol Genet; 2003 Nov; 12(21):2777-88. PubMed ID: 12966035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.
    Hu X; Xu X; Lu Z; Zhang P; Fassett J; Zhang Y; Xin Y; Hall JL; Viollet B; Bache RJ; Huang Y; Chen Y
    Hypertension; 2011 Oct; 58(4):696-703. PubMed ID: 21825219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
    Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
    Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basigin Promotes Cardiac Fibrosis and Failure in Response to Chronic Pressure Overload in Mice.
    Suzuki K; Satoh K; Ikeda S; Sunamura S; Otsuki T; Satoh T; Kikuchi N; Omura J; Kurosawa R; Nogi M; Numano K; Sugimura K; Aoki T; Tatebe S; Miyata S; Mukherjee R; Spinale FG; Kadomatsu K; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):636-46. PubMed ID: 26916734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.